This is a $113,253 firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Aging to King's College London, a non-profit organization based in the United Kingdom, for research services from September 29, 2013 to September 27, 2016. The contract does not have a set-aside designation. King's College London has previously performed prime federal contracts and subcontracts related to medical research, including...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the UK Health Security Agency (formerly known as Public Health England) as a delivery order under the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery contract. The $1,662,002 task order is for the provision of biological animal models and medical countermeasure development services to...
This contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to a prime contractor for R&D, Other Services, and Advanced Development services. The contract has a ceiling value of $1,212,120.00 and was awarded on September 15, 2002, with a final completion date of December 31, 2007. The contract is a definitive contract with an "Other" pricing type and does not have a set-aside designation. The place of performance is...
This is a definitive cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Porton Biopharma Limited, a foreign-owned for-profit organization, with a ceiling value of $12,323,733.00. The contract was awarded as a result of a novation, with the prior contract HHSN272201200032C with Public Health England now being HHSN272201600045C with Porton Biopharma Limited as the successor-in-interest contractor. The contract does not...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. Department of Health and Human Services (HHS), to Wolfson College at the University of Oxford. The $16,000.00 firm-fixed-price purchase order is for unspecified "other functions" and "college education for PhD." The contract does not have a set-aside designation and was awarded on October 1, 2013 with an ultimate completion date of the same...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., to facilitate the conduct of an observational study to characterize patients with COVID-19 infection (10,000 subjects). The contract has a ceiling value of $18,109,529.00 with a period of performance through January 31, 2027. It is a cost-plus-fixed-fee delivery order contract with no set-aside...
This is a $144,000.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Cambridge in the United Kingdom. The contract supports the Continuing Students Cambridge Current Scholars of the Doctoral Partnership Training Program, which provides graduate-level tuition and fees for NIH Fellows participating in the Oxford-Cambridge University Doctoral Partnership. The...
This is a $20,000.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), a civilian federal agency. The award is for the 2016 NIH Global Doctoral Partnership Program (NGDP) Annual Workshop, which accommodates 40 participants. The University of Oxford, a non-profit, state-controlled institution of higher learning located in the United Kingdom, is the prime contractor. This...
This federal contract award, with an ID of 75N91019D00024|75N91020F00014, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract supports NIAID's goal to better understand the coronavirus, with an initial focus on the ACTIV3 clinical trial. The task order will initiate the management, oversight, and conduct of the NIAID DCR...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is a component of the National Institutes of Health (NIH), to the University of Oxford. The $16,000.00 firm fixed-price purchase order is for the AMBIS #1747187 PAUL KIRK REARDON NEW MEMBER OF THE NIH OXFORD-CAMBRIDGE SCHOLARS PROGRAM, with a performance period ending on August 6, 2016. The contract was not set aside for any specific business category. The University of Oxford is...